173 related articles for article (PubMed ID: 37604934)
21. [The association of HLA-DR4 gene subtypes with Vogt-Koyanagi-Harada syndrome].
Xiao T; Jiang Y; You X
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):268-71. PubMed ID: 10451958
[TBL] [Abstract][Full Text] [Related]
22. Development of Vogt-Koyanagi-Harada disease-like uveitis during treatment by anti-programmed death-1 antibody: a case report.
Wang JN; Zhang Y; Huang CY; Li K; Yu XB
BMC Ophthalmol; 2024 Jun; 24(1):240. PubMed ID: 38849786
[TBL] [Abstract][Full Text] [Related]
23. Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database.
Anquetil C; Salem JE; Lebrun-Vignes B; Touhami S; Desbois AC; Maalouf G; Domont F; Allenbach Y; Cacoub P; Bodaghi B; Saadoun D
J Autoimmun; 2020 Jul; 111():102454. PubMed ID: 32303423
[TBL] [Abstract][Full Text] [Related]
24. Strong association of HLA class II sequences in Mexicans with Vogt-Koyanagi-Harada's disease.
Alaez C; del Pilar Mora M; Arellanes L; Cano S; Perez-Luque E; Vazquez MN; Olivo A; Burguete A; Hernandez A; Pedroza M; Gorodezky C
Hum Immunol; 1999 Sep; 60(9):875-82. PubMed ID: 10527396
[TBL] [Abstract][Full Text] [Related]
25. KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.
Levinson RD; Yung M; Meguro A; Ashouri E; Yu F; Mizuki N; Ohno S; Rajalingam R
PLoS One; 2016; 11(8):e0160392. PubMed ID: 27490240
[TBL] [Abstract][Full Text] [Related]
26. HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California.
Levinson RD; See RF; Rajalingam R; Reed EF; Park MS; Rao NA; Holland GN
Hum Immunol; 2004 Dec; 65(12):1477-82. PubMed ID: 15603876
[TBL] [Abstract][Full Text] [Related]
27. New insights into Vogt-Koyanagi-Harada disease.
Damico FM; Bezerra FT; Silva GC; Gasparin F; Yamamoto JH
Arq Bras Oftalmol; 2009; 72(3):413-20. PubMed ID: 19668980
[TBL] [Abstract][Full Text] [Related]
28. A variant of CLEC16A gene confers protection for Vogt-Koyanagi-Harada syndrome but not for Behcet's disease in a Chinese Han population.
Li K; Hou S; Qi J; Kijlstra A; Yang P
Exp Eye Res; 2015 Mar; 132():225-30. PubMed ID: 25576669
[TBL] [Abstract][Full Text] [Related]
29. Gut microbial signatures and their functions in Behcet's uveitis and Vogt-Koyanagi-Harada disease.
Wang Q; Wu S; Ye X; Tan S; Huang F; Su G; Kijlstra A; Yang P
J Autoimmun; 2023 May; 137():103055. PubMed ID: 37208257
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome.
Li K; Yang P; Zhao M; Hou S; Du L; Zhou H; Kijlstra A
Mol Vis; 2009 May; 15():955-61. PubMed ID: 19452015
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH
Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
[TBL] [Abstract][Full Text] [Related]
32. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans.
Kim MH; Seong MC; Kwak NH; Yoo JS; Huh W; Kim TG; Han H
Am J Ophthalmol; 2000 Feb; 129(2):173-7. PubMed ID: 10682969
[TBL] [Abstract][Full Text] [Related]
33. A COVID-19 perspective of Vogt-Koyanagi-Harada disease.
Dutta Majumder P; Sadhu S; González-López JJ; Mochizuki M
Indian J Ophthalmol; 2023 Jun; 71(6):2587-2591. PubMed ID: 37322685
[TBL] [Abstract][Full Text] [Related]
34. Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer.
Ushio R; Yamamoto M; Miyasaka A; Muraoka T; Kanaoka H; Tamura H; Kaneko A; Izawa A; Hirama N; Teranishi S; Manabe S; Inoue T; Shibata K; Sugiura Y; Kudo M; Kaneko T
Intern Med; 2021 Nov; 60(22):3593-3598. PubMed ID: 34092725
[TBL] [Abstract][Full Text] [Related]
35. A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.
Sheereen A; Gaafar A; Iqneibi A; Eldali A; Tabbara KF; Adra C; Al-Hussein K
Mol Vis; 2011; 17():3523-8. PubMed ID: 22219647
[TBL] [Abstract][Full Text] [Related]
36. Molecular Genetic Advances in Uveitis.
Hou S; Kijlstra A; Yang P
Prog Mol Biol Transl Sci; 2015; 134():283-98. PubMed ID: 26310161
[TBL] [Abstract][Full Text] [Related]
37. [Association of HLA-DQA1 and DQB1 alleles with Vogt-Koyanagi-Harada syndrome in Han Chinese population].
Liu Q; Zhang M; Qiu C; Hu T
Zhonghua Yan Ke Za Zhi; 1999 May; 35(3):210-5. PubMed ID: 11835809
[TBL] [Abstract][Full Text] [Related]
38. A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy.
Minami K; Egawa M; Kajita K; Murao F; Mitamura Y
Case Rep Ophthalmol; 2021; 12(3):952-960. PubMed ID: 35082654
[TBL] [Abstract][Full Text] [Related]
39. HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia.
Davis JL; Mittal KK; Freidlin V; Mellow SR; Optican DC; Palestine AG; Nussenblatt RB
Ophthalmology; 1990 Sep; 97(9):1137-42. PubMed ID: 2234843
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Alromaih AZ; Almater AI; Albloushi AF; Alkheraiji NF; Abu El-Asrar AM
Int Ophthalmol; 2023 Jan; 43(1):185-195. PubMed ID: 35945413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
